Journal Article

Niraparib Efficacy and Safety in Patients With BRCA-Mutated Ovarian Cancer: Results From Three Phase 3 Niraparib Trials

Clinical Advances in Hematology and Oncology (2021) 19(8) 7-8
DOI: 10.1200/jco.2021.39.15_suppl.5518
0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Niraparib Efficacy and Safety in Patients With BRCA-Mutated Ovarian Cancer: Results From Three Phase 3 Niraparib Trials. (2021). Clinical Advances in Hematology and Oncology, 19(8), 7–8. https://doi.org/10.1200/jco.2021.39.15_suppl.5518

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free